Optimal timing of injection of once-daily insulin glargine in people with type 1 diabetes using insulin lispro at meal-times

被引：0
|
作者：
Ashwell, SG
Home, PD
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A118 / A118
页数：1
相关论文
共 50 条
  • [1] Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times
    Ashwell, SG
    Gebbie, J
    Home, PD
    DIABETIC MEDICINE, 2006, 23 (01) : 46 - 52
  • [2] Twice-daily compared with once-daily insulin glargine in people with type 1 diabetes using meal-time insulin aspart
    Ashwell, SG
    Gebbie, J
    Home, PD
    DIABETES, 2005, 54 : A119 - A119
  • [3] Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart
    Ashwell, S. G.
    Gebbie, J.
    Home, P. D.
    DIABETIC MEDICINE, 2006, 23 (08) : 879 - 886
  • [4] Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes A randomized open parallel multicenter study
    Bolli, Geremia B.
    Kerr, David
    Thomas, Reena
    Torlone, Elisabetta
    Sola-Gazagnes, Agnes
    Vitacolonna, Ester
    Selam, Jean Louis
    Home, Philip D.
    DIABETES CARE, 2009, 32 (07) : 1170 - 1176
  • [5] Insulin lispro mix 25/75 twice daily (LM25) vs basal insulin glargine once daily and prandial insulin lispro once daily (BP) in type 2 diabetes: insulin intensification
    Tinahones, F. J.
    Gross, J. L.
    Onaca, A.
    Zhou, Z.
    Cleall, S.
    Rodriguez, A.
    DIABETOLOGIA, 2013, 56 : S412 - S412
  • [6] Comparison of insulin glargine injection at lunchtime, dinner-time and bedtime in people with Type 1 diabetes using mealtime insulin lispro
    Ashwell, SG
    Gebbie, J
    Home, PD
    DIABETOLOGIA, 2004, 47 : A302 - A302
  • [7] Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial
    Bretzel, Reinhard G.
    Nuber, Ulrike
    Landgraf, Wolfgang
    Owens, David R.
    Bradley, Clare
    Linn, Thomas
    LANCET, 2008, 371 (9618): : 1073 - 1084
  • [8] Two phase 3 trials of 3-times weekly insulin degludec versus once-daily insulin glargine in insulin-naive people with type 2 diabetes
    DeVries, J. H.
    Ratner, R. E.
    Bode, B. W.
    Russell-Jones, D. L.
    Begtrup, K.
    Johansen, T.
    Zinman, B.
    DIABETOLOGIA, 2012, 55 : S21 - S22
  • [9] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial
    Tinahones, F. J.
    Gross, J. L.
    Onaca, A.
    Cleall, S.
    Rodriguez, A.
    DIABETES OBESITY & METABOLISM, 2014, 16 (10): : 963 - 970
  • [10] Comparison of a multiple daily injection regimen with once-daily insulin glargine basal insulin and mealtime lispro, to continuous subcutaneous insulin infusion: a randomized, open, parallel study
    Bolli, GB
    Capani, F
    Kerr, D
    Thomas, R
    Torlone, E
    Selam, JL
    Sola-Gazagnes, A
    Vitacolonna, E
    DIABETOLOGIA, 2004, 47 : A301 - A301
12345